Ketamine Improves Desensitization of µ-Opioid Receptors Induced by Repeated Treatment with Fentanyl but Not with Morphine.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
10 03 2022
Historique:
received: 13 02 2022
revised: 08 03 2022
accepted: 09 03 2022
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 30 4 2022
Statut: epublish

Résumé

The issue of tolerance to continuous or repeated administration of opioids should be addressed. The ability of ketamine to improve opioid tolerance has been reported in clinical studies, and its mechanism of tolerance may involve improved desensitization of μ-opioid receptors (MORs). We measured changes in MOR activity and intracellular signaling induced by repeated fentanyl and morphine administration and investigated the effects of ketamine on these changes with human embryonic kidney 293 cells expressing MOR using the CellKey™, cADDis cyclic adenosine monophosphate, and PathHunter

Identifiants

pubmed: 35327617
pii: biom12030426
doi: 10.3390/biom12030426
pmc: PMC8946650
pii:
doi:

Substances chimiques

Analgesics, Opioid 0
Receptors, Opioid 0
beta-Arrestins 0
Ketamine 690G0D6V8H
Morphine 76I7G6D29C
Fentanyl UF599785JZ

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Références

Biomed Pharmacother. 2021 Sep;141:111800
pubmed: 34175819
Crit Care Med. 2018 Sep;46(9):e825-e873
pubmed: 30113379
Curr Top Med Chem. 2020;20(31):2822-2829
pubmed: 33115393
J Pain. 2016 Feb;17(2):131-57
pubmed: 26827847
Cochrane Database Syst Rev. 2017 Jun 28;6:CD003351
pubmed: 28657160
Trends Pharmacol Sci. 2020 Dec;41(12):947-959
pubmed: 33097283
Anesthesiology. 2021 Apr 1;134(4):645-659
pubmed: 32991672
Curr Opin Neurobiol. 2016 Feb;36:112-7
pubmed: 26687375
Pharmacology. 2007;79(4):236-42
pubmed: 17435392
Br J Pharmacol. 2020 Jul;177(13):2923-2931
pubmed: 32052419
Anesth Analg. 2001 Dec;93(6):1495-500, table of contents
pubmed: 11726430
Cochrane Database Syst Rev. 2018 Dec 20;12:CD012033
pubmed: 30570761
Cell Signal. 2018 Nov;51:86-98
pubmed: 30075183
Br J Pharmacol. 2008 Mar;153 Suppl 1:S379-88
pubmed: 18059321
J Clin Oncol. 1987 Jun;5(6):956-61
pubmed: 3585450
J Biol Chem. 1998 Mar 27;273(13):7637-42
pubmed: 9516468
N Engl J Med. 2019 Jan 24;380(4):365-378
pubmed: 30673555
Br J Pharmacol. 2018 Jul;175(14):2857-2868
pubmed: 28378462
Cell. 2017 Nov 16;171(5):1165-1175.e13
pubmed: 29149605
J Mol Signal. 2014 Mar 06;9(1):1
pubmed: 24597858
Pharmacol Rev. 2011 Dec;63(4):1001-19
pubmed: 21873412
J Biol Chem. 2012 Apr 27;287(18):14782-91
pubmed: 22378794
Pharmacol Rev. 2013 Jan 15;65(1):223-54
pubmed: 23321159
Anesthesiology. 2011 Feb;114(2):401-11
pubmed: 21245733
Front Pharmacol. 2021 Feb 02;11:599721
pubmed: 33708116
Lancet. 2019 Apr 13;393(10180):1558-1568
pubmed: 30983591
Reg Anesth Pain Med. 2018 Jul;43(5):456-466
pubmed: 29870457
Br J Anaesth. 1979 Dec;51(12):1167-73
pubmed: 526385
Biomolecules. 2021 Feb 04;11(2):
pubmed: 33557162
PLoS One. 2016 Oct 27;11(10):e0165461
pubmed: 27788221
Exp Ther Med. 2021 Sep;22(3):1004
pubmed: 34345286
Pharmacol Rev. 2018 Jul;70(3):621-660
pubmed: 29945898
Peptides. 2019 May;115:51-58
pubmed: 30890355
Pain. 2017 Mar;158(3):463-470
pubmed: 28067693
J Biol Chem. 1997 Oct 24;272(43):27005-14
pubmed: 9341139
J Opioid Manag. 2011 Mar-Apr;7(2):99-107
pubmed: 21561033
Front Pharmacol. 2014 Dec 18;5:280
pubmed: 25566076
J Neurochem. 2011 Oct;119(2):294-302
pubmed: 21692801
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2562-2567
pubmed: 28223524
J Pharmacol Sci. 2019 Jun;140(2):171-177
pubmed: 31320243
Anesthesiology. 1999 Jan;90(1):174-82
pubmed: 9915326
Anesth Analg. 1982 Feb;61(2):87-92
pubmed: 7198883
Molecules. 2021 Oct 08;26(19):
pubmed: 34641621
J Biol Chem. 2005 Mar 11;280(10):9528-35
pubmed: 15634674
Nat Rev Mol Cell Biol. 2018 Oct;19(10):638-653
pubmed: 30104700
Nat Rev Drug Discov. 2017 Jul;16(7):472-486
pubmed: 28303025

Auteurs

Yusuke Mizobuchi (Y)

Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikatacho, Kita-ku, Okayama-shi 700-8558, Japan.
Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.
Department of Anesthesiology and Critical Care Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Kanako Miyano (K)

Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.

Sei Manabe (S)

Department of Anesthesiology and Resuscitology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-shi 700-8558, Japan.

Eiko Uezono (E)

Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.
Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Akane Komatsu (A)

Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Yui Kuroda (Y)

Department of Anesthesiology and Pain Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan.

Miki Nonaka (M)

Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.

Yoshikazu Matsuoka (Y)

Department of Anesthesiology and Resuscitology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-shi 700-8558, Japan.

Tetsufumi Sato (T)

Department of Anesthesiology and Critical Care Medicine, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan.

Yasuhito Uezono (Y)

Department of Pain Control Research, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo 105-8461, Japan.
Supportive and Palliative Care Research Support Office, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa-shi 277-8577, Japan.

Hiroshi Morimatsu (H)

Department of Anesthesiology and Resuscitology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikatacho, Kita-ku, Okayama-shi 700-8558, Japan.
Department of Anesthesiology and Resuscitology, Okayama University Hospital, 2-5-1 Shikatacho, Kita-ku, Okayama-shi 700-8558, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH